Man charged with biotech exec's murder; Amgen names former Northrop Grumman exec to board;

 @FierceBiotech: FDA asks NicOx for new naproxcinod trial. Article | Follow @FierceBiotech

> The San Diego Police Department said Wednesday that murder charges have been filed in the death of John G. Watson, a member of the San Diego Tech Coast Angels, who was found dead in June. According to authorities, Kent Thomas Keigwin, age 59, has been charged by the San Diego County District Attorney's Office with the murder of Watson, who had been found by fellow angel investors when he failed to show for a meeting. Item

> Amgen announced that it has appointed Ronald Sugar to the company's board. Dr. Sugar, 61, is chairman emeritus of Northrop Grumman Corp. and served as the company's chairman and CEO from 2003 to 2009. He was president and chief operating officer of Northrop from 2001 to 2003. He has been a director of Chevron Corporation since 2005. Release

> The University of Michigan gave AnnArbor.com and other media members a tour of rarely seen parts of its latest treasure, the 174-acre ex-Pfizer complex in northern Ann Arbor. Video

> For the second time in a month, a Maryland bioscience company has filed for bankruptcy. But unlike Cyto Pulse Sciences of Glen Burnie, which filed for Chapter 7 liquidation, Correlogic of Germantown has filed for Chapter 11 protection and plans to soldier on with its cancer test candidate. News

> The former Pfizer Global Research and Development office complex off Pequot Avenue, which the pharmaceutical giant spent almost $300 million to construct less than a decade ago, has been sold to Electric Boat for $55 million, according to documents filed Thursday in City Hall. Report

> Proton Laboratories CEO Armando Casciati, announced today that the strategic milestones set for PLBI are on track and coming to fruition. Release

And Finally... If Cheech and Chong had sickle cell disease, chances are they wouldn't have felt nuthin'. A University of Minnesota medical school research team said Thursday that cannibinoids, a synthetic compound based on marijuana derivatives, could effectively ease pain in patients suffering from sickle cell disease (SCD). Article

Suggested Articles

The NIH is starting with Eli Lilly and AbCellera's COVID-19 antibody but could add more prospects as the trial goes on.

The series B positions ex-AveXis executives to build a biotech with a broad gene therapy pipeline and infrastructure to match.

A variant of the ACE2 receptor could work as a COVID-19 therapeutic by drawing the virus away from healthy cells, scientists reported.